Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment

Published:2009-09 Issue:1 Volume:86 Page:42-47
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Luef G.,Rauchenzauner M.,Waldmann M.,Sturm W.,Sandhofer A.,Seppi K.,Trinka E.,Unterberger I.,Ebenbichler C.F.,Joannidis M.,Walser G.,Bauer G.,Hoppichler F.,Lechleitner M.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference40 articles.

1. Influence of valproic acid on hepatic carbohydrate and lipid metabolism;Becker;Arch. Biochem. Biophys.,1983

2. Prevalence of and risk factors for hepatic steatosis in Northern Italy;Bellentani;Ann. Intern. Med.,2000

3. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy;Biton;Neurology,2001

4. Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite 2-n-propyl-4-pentenoic acid;Bjorge;Biochem. Biophys. Res. Commun.,1985

5. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity;Bonora;Diabetes Care,2000

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Simulation Study: Exploring the Impact of Clinical Parameters on Lamotrigine for Different Patient Populations with Implications for Liver Function Assessment and Therapeutic Drug Monitoring;Scientia Pharmaceutica;2024-02-28

2. Hepatoprotective effects of natural drugs: Current trends, scope, relevance and future perspectives;Phytomedicine;2023-12

3. Relationship of valproic acid, hepatosteatosis and serum betatrophin;2023-10-03

4. Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities;International Journal of Molecular Sciences;2023-08-25

5. Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key;International Journal of Molecular Sciences;2023-06-27